Novel Gene Therapy for Drug-Resistant Melanoma: Synergistic Combination of PTEN Plasmid and BRD4 PROTAC Loaded Lipid Nanocarriers

Researchers identified a novel combinatorial therapeutic strategy by targeting loss of PTEN tumor suppressor gene and upregulated BRD4 oncoprotein as Myc-dependent vulnerabilities of drug-resistant melanoma.